Protein detail
CD248
Endosialin (Tumor endothelial marker 1) (CD antigen CD248)
Entry name CD248 | UniProt ID | EVMP confidence score 0.72 |
Supporting publications (n) 11 | Transmembrane count 1 | Protein classification CD markersPredicted membrane proteins |
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30Basic Information
Protein Names
Endosialin (Tumor endothelial marker 1) (CD antigen CD248)
Protein Class (2)
CD markersPredicted membrane proteins
Protein Function
CD markers
Transmembrane
688..708; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym (2)
CD164L1TEM1
Gene Description
CD248 molecule
Chromosome
11
Position
66314494-66317044
Supporting publications (n)
11
EVMP confidence score
0.72
Fluorescence & Localization
Tissue SpecifictestisCell SpecificEarly spermatidsBlood Cell SpecificneutrophilBlood Lineage Specificgranulocytes
Function & Pathway
Protein Function
CD markers
Cellular Component (4)
Molecular Function (6)
Biological Process (3)
Mediation Categories (2)
Clinical-translation mediationFusion and delivery mediation
Relations & Evidence44
Ligand-Receptor Signaling (43)
43 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| plasma_membrane_transmembrane | plasma_membrane_transmembrane | OmniPath | Yes | ||||
| cell_surface | cell_surface | Surfaceome | Yes | ||||
| cell_surface | cell_surface | connectomeDB2020 | Yes | ||||
| cell_surface | cell_surface | OmniPath | Yes | ||||
| ligand | ligand | ICELLNET | Yes | Yes | |||
| cytokine | ligand | ICELLNET | Yes | Yes | |||
| ligand | ligand | OmniPath | Yes | Yes | |||
| receptor | receptor | connectomeDB2020 | Yes | Yes | |||
| receptor | receptor | Almen2009 | Yes | Yes | |||
| transmembrane | transmembrane_predicted | Phobius | Yes |
Isolation & Detection Technology (1)
Sequence, Structure & Domains
Sequences
Length
757
Mass
80,859
Sequence
MLLRLLLAWAAAGPTLGQDPWAAEPRAACGPSSCYALFPRRRTFLEAWRACRELGGDLATPRTPEEAQRVDSLVGAGPASRLLWIGLQRQARQCQLQRPLRGFTWTTGDQDTAFTNWAQPASGGPCPAQRCVALEASGEHRWLEGSCTLAVDGYLCQFGFEGACPALQDEAGQAGPAVYTTPFHLVSTEFEWLPFGSVAAVQCQAGRGASLLCVKQPEGGVGWSRAGPLCLGTGCSPDNGGCEHECVEEVDGHVSCRCTEGFRLAADGRSCEDPCAQAPCEQQCEPGGPQGYSCHCRLGFRPAEDDPHRCVDTDECQIAGVCQQMCVNYVGGFECYCSEGHELEADGISCSPAGAMGAQASQDLGDELLDDGEDEEDEDEAWKAFNGGWTEMPGILWMEPTQPPDFALAYRPSFPEDREPQIPYPEPTWPPPLSAPRVPYHSSVLSVTRPVVVSATHPTLPSAHQPPVIPATHPALSRDHQIPVIAANYPDLPSAYQPGILSVSHSAQPPAHQPPMISTKYPELFPAHQSPMFPDTRVAGTQTTTHLPGIPPNHAPLVTTLGAQLPPQAPDALVLRTQATQLPIIPTAQPSLTTTSRSPVSPAHQISVPAATQPAALPTLLPSQSPTNQTSPISPTHPHSKAPQIPREDGPSPKLALWLPSPAPTAAPTALGEAGLAEHSQRDDRWLLVALLVPTCVFLVVLLALGIVYCTRCGPHAPNKRITDCYRWVIHAGSKSPTEPMPPRGSLTGVQTCRTSV
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q9HCU0-1; Sequence=Displayed; Name=2; IsoId=Q9HCU0-2; Sequence=VSP_017087
Alternative Sequence
1..324; Missing (in isoform 2)
Domain & Motif Annotations
Compositional Bias
618..627; Low complexity; 748..757; Polar residues
Domain (FT)
30..156; C-type lectin; 162..232; Sushi; 312..351; EGF-like; calcium-binding
Region
618..662; Disordered; 737..757; Disordered
Clinical Relevance
Related Diseases (5)
Biomarker
Phase 2
Drugs (2)
Antibody